A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, tolerability, pharmacokinetics
(PK), and pharmacodynamics (PD) of JNJ-38518168 compared with placebo in participants with
persistent asthma that is inadequately controlled despite current treatment.